Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment

NCT00372372 is registered in ClinicalTrials.gov with Tuen Mun Hospital as lead sponsor.

NCT NCT00372372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00372372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy of Risedronate in Prevention of Bone Loss in Patients Receiving High Dose Corticosteroid Treatment
Lead sponsor
Tuen Mun Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2004
Completion date
April 30, 2007
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis